Deep eutectic solvents (DESs) are a more environmentally friendly, cost-effective, and recyclable alternative for ionic liquids. Since the number of possible deep is very large, there needs effective methods to predict physicochemical nature new that not met by currently available models. Here, we have built coarse-grained models few well-known actively studied using recently published Martini ...

Deep eutectic solvents (DESs) have always been attractive to scientists due to their wide range of applications, a great interest in diverse fields including nanotechnology due to their unique properties as new green solvents. It used large-scale for chemical and electrochemical synthesis nanomaterial. DESs have had also active role in improving the size and morphology of nanomaterial during sy...

Percutaneous coronary intervention (PCI) with stenting is increasingly being utilized for acute coronary syndromes (ACS), and the debate over the safety and efficacy of drug-eluting stents (DESs) versus bare-metal stents (BMSs) has intensified. The difficulty in consistently assessing stent safety is because of the widespread off-label use in patients with clinical features and coronary anatomy...

To date, many studies have been published, aiming to extract bioactive compounds from plants. Lately, research focuses on maximizing the extraction yield, using environmentally friendly techniques and solvents. In this study, of polyphenolic Cistus creticus is discussed. Extraction has carried out with water ethanol, employing most common approach. further enhance usage four deep eutectic solve...

Although not a definitive treatment, percutaneous coronary intervention offers a palliative benefit to patients with cardiac allograft vasculopathy. Given the superior outcomes with drug-eluting stents (DESs) over bare metal stents (BMSs) in native coronary artery disease, similar improvements might be expected in transplant patients; however, the results have been mixed. Consecutive cardiac tr...

BACKGROUND Second-generation drug-eluting stents (DESs) are known to have better safety and clinical outcomes compared with the first-generation DESs. We compared the clinical results of off-pump coronary artery bypass grafting (OPCAB) with percutaneous coronary intervention (PCI) using second-generation DESs. METHODS The study enrolled 1,821 patients with triple-vessel or left main coronary ...

Drug-eluting stents (DESs) have minimized the limitations of bare-metal stents (BMSs) after percutaneous coronary interventions. Nevertheless, serious concerns remain about possible late complications of stenting, such as stent thrombosis (ST) and in-stent restenosis (ISR), although the introduction of second-generation DESs seems to have softened the phenomenon, compared to the first-generatio...

Drug-eluting stents (DESs) have been central focused area of interest interventional cardiology ever since the RAVEL study was presented at the meeting of the European Society of Cardiology in September 2001. Their novelty, along with the promising preliminary results published for that study, aroused many expectations.1 Although these expectations have not been fully met and the rate of resten...

BACKGROUND Some modifications introduced in the design of the new generation of drug-eluting stent (DES) to improve their flexibility may entail a reduction in their longitudinal strength. This study sought to evaluate the longitudinal deformation of DESs by multislice computed tomography (MSCT). METHODS This study included DESs that could have been potentially deformed by mechanical actions ...